Phase III Randomized Trial of Vaccinia Melanoma Oncolysa

Wallack, Marc K.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA045358-02
• Application #: 3188465
• Study Section: Experimental Therapeutics Subcommittee 1 (ET)
• Project Start: 1990-02-01
• Project End: 1991-03-31
• Budget Start: 1991-02-01
• Budget End: 1991-03-31
• Support Year: 2
• Fiscal Year: 1991

Institution

• Name: Mount Sinai Medical Center (Miami Beach)
• DUNS #: 046025144
• City: Miami Beach
• State: FL
• Country: United States
• Zip Code: 33140

Publications

Wallack, M K; Sivanandham, M; Balch, C M et al. (1998) Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial. J Am Coll Surg 187:69-77;discussion 77-9